The total U.S. market for wound care is growing just below 4%, which will take the 2023 market value from $12.2 billion up to $15.6 billion by 2030. As a result of the market increase, we decided to outline the top wound care companies in the U.S. and provide some insights on their product portfolios, mergers, acquisitions, and overall market share.
Wish to Learn More About The U.S. Wound and Tissue Management Market?
Get a complimentary report summary today:
About Wound Care
Wound care is an ever-evolving medical device industry that prospers thanks to its considerable product innovation. Companies are constantly striving to create products that are easier for physicians to use, that fight infection, and that takes less time for wound closure. Due to these factors, this market is expected to increase in value over the coming years. The largest competitors in this field were almost able to collectively capture the majority of the $11 Billion wound care market in 2018. Products are offered at a variety of price points with diverse device portfolios. Diversification and product bundling are expected to have a significant impact on the industry competition in the near future. Reimbursement is also likely to have a large impact on this market as products sold for off-label uses may soon be no longer eligible for reimbursement. In the list below, companies are ranked (in descending order) by their share in the total U.S. wound care market in 2018.
Top 10 Wound Care Companies in the U.S. (2023 Update)
- Ethicon
- 3M
- Medtronic
- Cardinal Health
- Smith & Nephew
- Medline
- Baxter
- Organogenesis
- Integra Lifesciences
- MiMedx
Ethicon
In 2023, Ethicon dominated the wound and tissue management market, securing its position as the leading competitor. Known for its extensive and high-quality product portfolio, Ethicon leverages its strong brand names to offer bundled discounts, giving it a distinct competitive edge despite its premium pricing.
Ethicon’s leadership is particularly evident in the wound closure market, where it excels in sutures, stapling, ligation, skin adhesives, and cyanoacrylate-based skin closure systems. This dominance in wound closure, which accounts for over a quarter of the entire wound and tissue management market, firmly establishes Ethicon as the overall market leader. Beyond wound closure, Ethicon also leads in the hemostat market and maintains a formidable presence in the anti-adhesion and tissue sealant markets, further solidifying its top-tier status in the industry.
3M
3M, a global giant with over 90,000 employees, has solidified its standing in the healthcare sector by acquiring Acelity and its subsidiaries. This strategic move has significantly expanded 3M’s already strong portfolio, which includes static compression products as well as traditional and advanced wound dressings.
As a result, 3M secured its position as the second-leading company in the wound and tissue management market. Acelity’s contribution was pivotal, especially in the negative pressure wound therapy (NPWT) market, where its V.A.C.® systems dominate. Acelity also bolstered 3M’s presence in the dressing market with its antimicrobial and interactive dressings, along with non-adherent contact layer products. Given that NPWT represents the third-largest segment in the wound and tissue management market—and with 3M commanding over three-quarters of the NPWT market—3M has firmly established itself as a leading force in the industry.
Medtronic
In 2023, Medtronic emerged as the third-leading competitor in the wound and tissue management market, despite focusing exclusively on the wound closure segment. Medtronic’s dominance in this critical area, which represents a substantial portion of the overall market, propelled it to the top tier of competitors. The company’s stronghold on wound closure is powered by its extensive range of products, including sutures, staplers, ligating clip appliers, and cyanoacrylate-based tissue adhesives. This robust product lineup secured Medtronic’s position as a major force in the wound and tissue management market.
Cardinal Health
Cardinal Health is a powerhouse in the U.S. healthcare industry, supplying medical products to over 75% of hospitals nationwide. The company solidified its market dominance in 2017 by acquiring Medtronic’s patient recovery business, a strategic move that significantly expanded its market share. This acquisition catapulted Cardinal Health to the forefront of the traditional dressings market, where it now leads in providing essential products like cotton and gauze to hospitals.
Moreover, Cardinal Health’s acquisition included Medtronic’s dynamic deep vein thrombosis (DVT) prevention products, positioning the company as a leader in the dynamic compression market. The company’s extensive portfolio doesn’t stop there—its Kendall™ and AMD™ lines of advanced wound care dressings have secured a strong foothold in the antimicrobial dressing market. Even before this acquisition, Cardinal Health was a formidable competitor across multiple segments of the wound and tissue management market, and this expansion has only strengthened its competitive edge.
Smith & Nephew
Smith & Nephew, a leading British multinational in the medical device sector, has carved out a strong presence in the U.S. advanced wound dressing market, particularly in the antimicrobial and interactive wound dressing segments. Their ALLEVYN® product line shines in the advanced dressing market, dominating all moist dressing sub-segments, with exceptional performance in the rapidly expanding foam segment. The company is also a formidable player in the collagen and skin substitute markets with its BIOSTEP® collagen matrix dressings and OASIS® product.
Smith & Nephew’s acquisition of Osiris Therapeutics in 2019 has significantly bolstered its position in the interactive dressing market, underscoring its commitment to innovation and growth. Additionally, the company is a key participant in the static compression market. Over the past two years, its negative pressure wound therapy portfolio has seen impressive market share gains, setting the stage for even greater competitiveness in the coming years.
Additional Wound Care Companies
The sixth through tenth competitors were Medline, Baxter, Organogenesis, Integra Lifesciences, and MiMedx.
Smith & Nephew, a British multinational medical manufacturer, dominates the advanced wound dressing market, excelling in the antimicrobial and interactive wound dressing segments, boasting a comprehensive product line such as ALLEVYN® and making strategic acquisitions like Osiris Therapeutics to strengthen its position. Baxter leads the tissue sealant market with Tisseel® and Coseal®, renowned for being the first approved tissue sealant in the U.S., while its 2018 acquisition of Preveleak® further solidifies its presence. Organogenesis dominates the interactive dressing market with skin substitutes, facilitated by the success of PuraPly® and PuraPlyAM®. Integra LifeSciences is a major player in advanced dressing, tissue sealant, and surgical hemostat markets, gaining a stronger interactive dressing market foothold with the 2021 acquisition of Acell. MiMedx stands out in the skin substitute market with EpiFix®, benefiting from low manufacturing costs and Medicare reimbursement, and has expanded its product line with offerings like AmnioFix® and EpiCord®, leveraging its proprietary PURION® process and securing broad coverage through Medicare Administrative Contractors.
Explore Comprehensive U.S. Wound and Tissue Management Market Report Today!
For an in-depth understanding of these trends, delve into our detailed 2024 – 2030 U.S. Wound and Tissue Management Market Report.
This report offers a comprehensive analysis of the U.S. Wound and Tissue Management Market, covering:
- Wound Closure & Healing: Includes sutures, staples, adhesives, surgical hemostats, and tissue sealants.
- Wound Dressing: Traditional options plus advanced dressings like moist, antimicrobial, interactive, and non-adherent layers.
- Specialized Technologies: Anti-adhesion products, Negative Pressure Wound Therapy (NPWT), static compression therapy, and dynamic compression therapy.
Or request a complimentary U.S. Wound and Tissue Management Market Executive Summary, completely free.
